Open clinical trial of carbamazepine in chronic schizophrenic inpatients.
14 male chronic schizophrenic patients were treated over 3 months with carbamazepine, mostly as an adjunct to neuroleptics. Psychopathological status was assessed using the Brief Psychiatric Rating Scale. A significant improvement was found in the following categories: excitement (p less than 0.01) and tension (p less than 0.05). But no beneficial effect on the schizophrenic defect could be detected.
Wetterling
T
T
D000328:Adult; D002220:Carbamazepine / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D002220:Carbamazepine